Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Most of the enthusiasm for Gilead Sciences (NASDAQ: GILD) in recent months has focused on the antiviral drug Remdesivir. Gilead was also in the headlines last week after reports surfaced that the large pharmaceutical company AstraZeneca was interested in taking over the biotechnology. Could Gilead Sciences have an HIV cure ready?
Mention your own website in this post for Advertisement
Last News
‘Gorilla hail’ pounded parts of Texas. See photos and video from the powerful storm
Ford Bronco drops Vermont Off-Roadeo site after locals object